NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
Key Highlights
- ➤NeOnc (NTHI) shares cleared $3 resistance on stronger trading volume
- ➤Reported short interest rose 45.1% to 757,739 shares by September 30
- ➤NeOnc signed an MOU with Department of Health–Abu Dhabi on October 21
- ➤Two Abu Dhabi children are receiving investigational NEO100 through Compassionate Care
- ➤Analyst price targets range from $13 to $20, averaging $17
DENVER, Oct. 23, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) cleared several key resistance levels, on strong trading volume, delivering a potentially important technical signal for a stock that recently tested lows near $2.50. The breakout marks a significant development from its recent chart snapshots.
The move above $3 strengthens the technical reversal thesis. Before the breakout, NTHI had reclaimed its daily 9-day exponential moving average near $2.79, moved above the previously observed VWAP around $2.87, and shown an improving daily MACD histogram. Clearing $3 on stronger volume adds confirmation that buyers are showing greater conviction. The next areas to watch are $3.30–$3.40, where previous trading activity coincides with the declining 50-day EMA, followed by $3.50. A sustained move above those levels could further strengthen the breakout’s durability.
Get started
Create a free account to read the full story.